A1C, LDL, HDL… the number of medical abbreviations you might see on your patient portal is enough to make you think your ...

Altimmune ALT announced that the FDA has granted Breakthrough Therapy Designation to its lead pipeline candidate, pemvidutide ...

TAMPA, Fla. (WFLA) — Whenever you get bloodwork done, you probably don’t know what exactly you’re supposed to be looking at on the sheet (unless you’re a healthcare provider, that is). Glucose, sodium ...

Patients with nonalcoholic fatty liver disease may have normal alanine aminotransferase levels in spite of having advanced fibrosis, according to a new study. Patients with nonalcoholic fatty liver ...

Altimmune Inc. (NASDAQ: ALT) on Friday shared topline results from the IMPACT Phase 2b trial of pemvidutide. Patients had metabolic dysfunction-associated steatohepatitis (MASH) at 48 weeks. MASH is a ...

If you have high ALT levels — a liver enzyme known as alanine aminotransferase — it may be due to a liver problem. Here's what you need to know about these liver enzymes and how to lower your ALT ...

November 2, 2006 (Boston) — The currently accepted upper limit of normal for serum alanine aminotransferase (ALT) levels is "artificially high," officials from the American Association for the Study ...

Please provide your email address to receive an email when new articles are posted on . Patients with hepatitis B had a higher risk for hepatocellular carcinoma after HBV e antigen seroclearance if ...

Breakthrough Therapy Designation is intended to expedite the development and review of medicines that are intended to treat a serious or life-threatening condition and have shown preliminary clinical ...

On Thursday, Altimmune, Inc. (NASDAQ:ALT) released topline results from the IMPACT Phase 2b trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH). MASH is a severe liver ...

Routine blood tests are increasingly detecting elevated liver enzymes, which may signal liver stress or damage. While mild ...